tiprankstipranks
Matinas BioPharma (MTNB)
NYSE MKT:MTNB

Matinas BioPharma (MTNB) Technical Analysis

1,443 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
5Neutral
7Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Matinas BioPharma’s (MTNB) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Matinas BioPharma is a Sell.
Matinas BioPharma’s (MTNB) 20-Day exponential moving average is 0.17, while Matinas BioPharma’s (MTNB) share price is $0.179, making it a Buy.
Matinas BioPharma’s (MTNB) 50-Day exponential moving average is 0.17, while Matinas BioPharma’s (MTNB) share price is $0.179, making it a Buy.

Matinas BioPharma (MTNB) Pivot Points

Jul 21, 2024, 11:41 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.17
0.17
0.18
0.18
0.19
0.19
0.19
Fibonacci
0.17
0.18
0.18
0.18
0.19
0.19
0.19
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Matinas BioPharma (MTNB) Moving Averages

Jul 21, 2024, 11:41 PM
Period
Simple
Exponential
MA5
0.18Sell
0.18Buy
MA10
0.17Buy
0.18Buy
MA20
0.17Buy
0.17Buy
MA50
0.17Buy
0.17Buy
MA100
0.20Sell
0.19Sell
MA200
0.21Sell
0.20Sell
Matinas BioPharma’s (MTNB) 10-Day exponential moving average is 0.18, while Matinas BioPharma’s (MTNB) share price is $0.179, making it a Buy.
Matinas BioPharma’s (MTNB) 100-Day exponential moving average is 0.19, while Matinas BioPharma’s (MTNB) share price is $0.179, making it a Sell.
Matinas BioPharma’s (MTNB) stock price is $0.179 and Matinas BioPharma’s (MTNB) 50-day simple moving average is 0.17, creating a Buy signal.
Matinas BioPharma’s (MTNB) stock price is $0.179 and Matinas BioPharma’s (MTNB) 100-day simple moving average is 0.20, creating a Sell signal.
Matinas BioPharma’s (MTNB) stock price is $0.179 and Matinas BioPharma’s (MTNB) 200-day simple moving average is 0.21, creating a Sell signal.

Matinas BioPharma (MTNB) Technical Indicators

Jul 21, 2024, 11:41 PM
Name
Value
Implied Action
RSI (14)
60.05
Neutral
STOCH (9,6)
62.50
Neutral
STOCHRSI (14)
69.23
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
28.30
Neutral
Williams %R
-30.77
Buy
CCI (14)
104.80
Sell
ATR (14)
0.01
-
Ultimate Oscillator
58.08
Neutral
ROC
12.50
Buy
Matinas BioPharma’s (MTNB) Relative Strength Index (RSI) is 60.05, creating a Neutral signal.
Matinas BioPharma’s (MTNB) Trend Strength Indicator (ADX) is 28.30, creating a Neutral signal.
Matinas BioPharma’s (MTNB) Commodity Channel Index (CCI) is 104.80, creating a Sell signal.
Matinas BioPharma’s (MTNB) Price Rate of Change (ROC) is 12.50, creating a Buy signal.

FAQ

Is MTNB a Buy, Hold, or Sell?
Based on MTNB’s technical indicators, MTNB is a Buy.
    What is MTNB’s RSI (14)?
    MTNB’s RSI (14) is 60.05, which suggests MTNB is a Neutral.
      What is MTNB’s MACD?
      MTNB’s MACD is <0.01, which suggests MTNB is a Sell.
        What is MTNB’s 5-day moving average?
        MTNB’s 5-day moving average is 0.18, which suggests MTNB is a Sell.
          What is MTNB’s 20-day moving average?
          MTNB 20-day moving average is 0.17, which suggests MTNB is a Buy.
            What is MTNB’s 50-day moving average?
            MTNB’s 50-day moving average is 0.17, which suggests MTNB is a Buy.
              What is MTNB’s 200-day moving average?
              MTNB’s 200-day moving average is 0.21, which suggests MTNB is a Sell.
                What is MTNB’s Williams % R (14)?
                MTNB’s Williams % R (14) is -30.77, which suggests MTNB is a Buy.
                  What is MTNB’s CCI (14)?
                  MTNB’s CCI (14) is 104.80, which suggests MTNB is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis